Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 82
Page 36
H33 H34 H35 H36 H37 H38 the disclosure of the invention in the specification and then decide whether it was enabling . The fact that a claim was not clear or was not supported by the specification was likely to be irrelevant . There was ...
H33 H34 H35 H36 H37 H38 the disclosure of the invention in the specification and then decide whether it was enabling . The fact that a claim was not clear or was not supported by the specification was likely to be irrelevant . There was ...
Page 50
... specification states at the outset that the invention “ relates generally to the manipulation of genetic materials and , more particularly , to recombinant procedures making possible the production of polypeptides possessing part or all ...
... specification states at the outset that the invention “ relates generally to the manipulation of genetic materials and , more particularly , to recombinant procedures making possible the production of polypeptides possessing part or all ...
Page 80
... specification had been framed in good faith and with reasonable skill . To do so , he had to look both at the specification in the form that the patent was granted and in the form after amendment in the European Patent Office in 1999 ...
... specification had been framed in good faith and with reasonable skill . To do so , he had to look both at the specification in the form that the patent was granted and in the form after amendment in the European Patent Office in 1999 ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word